Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease

Wallace SE and Wilcox WR: Camurati-Engelmann DiseaseGene Reviews (R). University of Washington; Seattle (WA): 1993

Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, Guañabens N, Migone N, Wientroub S, Divizia MT, et al: Camurati-Engelmann disease: Review of the clinical, radiological and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet. 43:1–11. 2006.PubMed/NCBI

Bartuseviciene A, Samuilis A and Skucas J: Camurati-Engelmann disease: Imaging, clinical features and differential diagnosis. Skeletal Radiol. 38:1037–1043. 2009. View Article : Google Scholar : PubMed/NCBI

Carlson ML, Beatty CW, Neff BA, Link MJ and Driscoll CL: Skull base manifestations of Camurati-Engelmann disease. Arch Otolaryngol Head Neck Surg. 136:566–575. 2010. View Article : Google Scholar : PubMed/NCBI

Janssens K, Gershoni-Baruch R, Guañabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L and Van Hul W: Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet. 26:273–275. 2000. View Article : Google Scholar : PubMed/NCBI

Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, et al: Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet. 26:19–20. 2000. View Article : Google Scholar : PubMed/NCBI

de Vernejoul MC: Sclerosing bone disorders. Best Pract Res Clin Rheumatol. 22:71–83. 2008. View Article : Google Scholar : PubMed/NCBI

Lucke T, Illsinger S, Das AM, Schirg E and Hartmann H: Pitfalls in paediatric gait disturbances: Painless bone diseases. Eur J Pediatr. 165:909–912. 2006. View Article : Google Scholar : PubMed/NCBI

Cohen MM Jr: The new bone biology: Pathologic, molecular, and clinical correlates. Am J Med Genet A. 140:2646–2706. 2006.PubMed/NCBI

Ayyavoo A, Derraik JG, Cutfield WS and Hofman PL: Elimination of pain and improvement of exercise capacity in Camurati-Engelmann disease with losartan. J Clin Endocrinol Metab. 99:3978–3982. 2014. View Article : Google Scholar : PubMed/NCBI

Toumba M, Neocleous V, Shammas C, Anastasiadou V, Allgrove J, Phylactou LA and Skordis N: A family with Camurati-Engelman disease: The role of the missense p. R218C mutation in TGFbeta1 in bones and endocrine glands. J Pediatr Endocrinol Metab. 26:1189–1195. 2013.PubMed/NCBI

Wang C, Zhang BH, Liu YJ, Hu YQ, He JW and Zhang ZL: Transforming growth factor-β1 gene mutations and phenotypes in pediatric patients with Camurati-Engelmann disease. Mol Med Rep. 7:1695–1699. 2013.PubMed/NCBI

Wu S, Liang S, Yan Y, Wang Y, Li F, Deng Y, Huang W, Yuan W, Luo N, Zhu C, et al: A novel mutation of TGF beta1 in a Chinese family with Camurati-Engelmann disease. Bone. 40:1630–1634. 2007. View Article : Google Scholar : PubMed/NCBI

Hernàndez MV, Peris P, Guañabens N, Alvarez L, Monegal A, Pons F, Ponce A and Muñoz-Gómez J: Biochemical markers of bone turnover in Camurati-Engelmann disease: A report on four cases in one family. Calcif Tissue Int. 61:48–51. 1997. View Article : Google Scholar : PubMed/NCBI

Cheloha RW, Gellman SH, Vilardaga JP and Gardella TJ: PTH receptor-1 signalling-mechanistic insights and therapeutic prospects. Nat Rev Endocrinol. 11:712–724. 2015. View Article : Google Scholar : PubMed/NCBI

Jang MG, Lee JY, Yang JY, Park H, Kim JH, Kim JE, Shin CS, Kim SY and Kim SW: Intermittent PTH treatment can delay the transformation of mature osteoblasts into lining cells on the periosteal surfaces. J Bone Miner Metab. 34:532–539. 2015.PubMed/NCBI